---

Related Articles:

Population pharmacokinetic/dynamic model of lymphosuppression after fludarabine administration.

2015-01-01

[Cancer Chemother. Pharmacol. 75(1) , 67-75, (2015)]

Fludarabine phosphate in the treatment of chronic lymphocytic leukemia: biology, clinical impact, and future directions.

1993-01-01

[Cancer Treat. Res. 64 , 105-19, (1993)]

Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies.

1991-01-01

[J. Clin. Oncol. 9(1) , 175-88, (1991)]

Metabolism and action of fludarabine phosphate.

1990-10-01

[Semin. Oncol. 17(5 Suppl 8) , 3-17, (1990)]

Fludarabine phosphate in the treatment of chronic lymphocytic leukemia.

1990-10-01

[Semin. Oncol. 17(5 Suppl 8) , 49-62, (1990)]